- Home
- OTLK vs AGFY Comparison
OTLK vs AGFY Comparison
Compare OTLK & AGFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- AGFY
- Stock Information
- Founded
- OTLK 2010
- AGFY 2016
- Country
- OTLK United States
- AGFY United States
- Employees
- OTLK N/A
- AGFY N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- AGFY Military/Government/Technical
- Sector
- OTLK Health Care
- AGFY Consumer Discretionary
- Exchange
- OTLK Nasdaq
- AGFY Nasdaq
- Market Cap
- OTLK 48.3M
- AGFY 50.6M
- IPO Year
- OTLK 2016
- AGFY 2021
- Fundamental
- Price
- OTLK $1.57
- AGFY $22.36
- Analyst Decision
- OTLK Strong Buy
- AGFY
- Analyst Count
- OTLK 5
- AGFY 0
- Target Price
- OTLK $9.60
- AGFY N/A
- AVG Volume (30 Days)
- OTLK 796.7K
- AGFY 19.5K
- Earning Date
- OTLK 08-13-2025
- AGFY 08-13-2025
- Dividend Yield
- OTLK N/A
- AGFY N/A
- EPS Growth
- OTLK N/A
- AGFY N/A
- EPS
- OTLK 0.83
- AGFY N/A
- Revenue
- OTLK N/A
- AGFY $10,218,000.00
- Revenue This Year
- OTLK N/A
- AGFY N/A
- Revenue Next Year
- OTLK $379.84
- AGFY N/A
- P/E Ratio
- OTLK $1.91
- AGFY N/A
- Revenue Growth
- OTLK N/A
- AGFY 9.42
- 52 Week Low
- OTLK $0.87
- AGFY $2.71
- 52 Week High
- OTLK $9.25
- AGFY $84.44
- Technical
- Relative Strength Index (RSI)
- OTLK 40.37
- AGFY 42.58
- Support Level
- OTLK $1.65
- AGFY $19.75
- Resistance Level
- OTLK $2.04
- AGFY $21.75
- Average True Range (ATR)
- OTLK 0.12
- AGFY 1.97
- MACD
- OTLK -0.03
- AGFY -0.55
- Stochastic Oscillator
- OTLK 2.13
- AGFY 15.66
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About AGFY Agrify Corporation
Agrify Corp is a developer of branded inventive solutions for the cannabis and hemp industries. Its Senorita brand offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror cocktails like a margarita - in three flavors - classic Lime Jalapeno Margarita, Mango Margarita, and Paloma. In addition to beverages, Agrify has also historically been a provider of inventive cultivation and extraction solutions for the cannabis industry. Its comprehensive extraction product line, which includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.